FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023321844> ?p ?o ?g. }

• W2023321844 endingPage "712" @default.
• W2023321844 startingPage "705" @default.
• W2023321844 abstract "Bone loss occurs during the first 6 months after renal transplantation (RT), and corticosteroid therapy plays an important role. Although calcium plus vitamin D administration prevents corticosteroid-induced osteoporosis, its use in RT recipients is limited by the risk of hypercalcemia.This double-blind, randomized, and controlled prospective intervention trial examined the effect of intermittent calcitriol (0.5 microg/48 h) during the first 3 months after RT, plus oral calcium supplementation (0.5 g/day) during 1 year with calcium supplementation alone. The primary outcome measure was the change in bone mineral density (BMD) at 3 and 12 months after RT; we also explored whether the effect of calcitriol on BMD was different among vitamin D receptor (VDR) genotypes (BsmI). Forty-five recipients were randomized to calcitriol therapy (CT) and 41 were randomized to placebo (PL).Both groups had a similar degree of pre-existing hyperparathyroidism (197 +/- 229 vs. 191 +/- 183 pg/mL), but a more pronounced decrease of parathyroid hormone (PTH) levels after RT was observed in CT patients (at 3 months: 61.4 +/- 42.2 vs. 85.7 +/- 53.1 pg/mL, P= 0.02; at 12 months: 67.3 +/- 33.7 vs. 82.6 +/- 37 pg/mL; P= 0.08). CT patients preserved their BMD at the total hip significantly better than those on PL (3 months: 0.04 +/- 3.3 vs. -1.93 +/- 3.2%, P= 0.01; 12 months: 0.32 +/- 4.8 vs. -2.17 +/- 4.4%, P= 0.03); significant differences were noted at the intertrochanter, trochanter, and Ward's triangle. Differences did not reach significance at the femoral neck. Two CT patients (4.4%) and 4 PL patients (9.8%) developed a hypercalcemic episode during the first 3 months after RT. The effect of CT on BMD at 3 months was more prominent in recipients with the at-risk allele of the VDR gene (P= 0.03).Therapy with low-dose calcium supplements during 1 year, plus intermittent calcitriol for 3 months after RT, is safe, decreases PTH levels more rapidly, and prevents bone loss at the proximal femur; a more pronounced effect is seen in recipients with at least one at-risk allele of the VDR genotype." @default.
• W2023321844 created "2016-06-24" @default.
• W2023321844 creator A5007723262 @default.
• W2023321844 creator A5016169847 @default.
• W2023321844 creator A5016879035 @default.
• W2023321844 creator A5017410873 @default.
• W2023321844 creator A5033420169 @default.
• W2023321844 creator A5066491567 @default.
• W2023321844 creator A5072000496 @default.
• W2023321844 creator A5074607712 @default.
• W2023321844 creator A5077029679 @default.
• W2023321844 creator A5079614063 @default.
• W2023321844 creator A5086062381 @default.
• W2023321844 date "2004-02-01" @default.
• W2023321844 modified "2023-10-17" @default.
• W2023321844 title "Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation" @default.
• W2023321844 cites W1900105093 @default.
• W2023321844 cites W1973889679 @default.
• W2023321844 cites W1981554514 @default.
• W2023321844 cites W2004079745 @default.
• W2023321844 cites W2005936777 @default.
• W2023321844 cites W2009180025 @default.
• W2023321844 cites W2009529772 @default.
• W2023321844 cites W2024355830 @default.
• W2023321844 cites W2025769734 @default.
• W2023321844 cites W2030059815 @default.
• W2023321844 cites W2033875033 @default.
• W2023321844 cites W2045947279 @default.
• W2023321844 cites W2056093504 @default.
• W2023321844 cites W2062218093 @default.
• W2023321844 cites W2081928163 @default.
• W2023321844 cites W2082467443 @default.
• W2023321844 cites W2088904749 @default.
• W2023321844 cites W2133161527 @default.
• W2023321844 cites W2143873208 @default.
• W2023321844 cites W2145437913 @default.
• W2023321844 cites W2165084323 @default.
• W2023321844 cites W2314674563 @default.
• W2023321844 cites W2336860975 @default.
• W2023321844 cites W2337884406 @default.
• W2023321844 cites W2622196867 @default.
• W2023321844 doi "https://doi.org/10.1111/j.1523-1755.2004.00432.x" @default.
• W2023321844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14717945" @default.
• W2023321844 hasPublicationYear "2004" @default.
• W2023321844 type Work @default.
• W2023321844 sameAs 2023321844 @default.
• W2023321844 citedByCount "110" @default.
• W2023321844 countsByYear W20233218442012 @default.
• W2023321844 countsByYear W20233218442013 @default.
• W2023321844 countsByYear W20233218442014 @default.
• W2023321844 countsByYear W20233218442015 @default.
• W2023321844 countsByYear W20233218442016 @default.
• W2023321844 countsByYear W20233218442017 @default.
• W2023321844 countsByYear W20233218442018 @default.
• W2023321844 countsByYear W20233218442019 @default.
• W2023321844 countsByYear W20233218442020 @default.
• W2023321844 countsByYear W20233218442021 @default.
• W2023321844 countsByYear W20233218442022 @default.
• W2023321844 countsByYear W20233218442023 @default.
• W2023321844 crossrefType "journal-article" @default.
• W2023321844 hasAuthorship W2023321844A5007723262 @default.
• W2023321844 hasAuthorship W2023321844A5016169847 @default.
• W2023321844 hasAuthorship W2023321844A5016879035 @default.
• W2023321844 hasAuthorship W2023321844A5017410873 @default.
• W2023321844 hasAuthorship W2023321844A5033420169 @default.
• W2023321844 hasAuthorship W2023321844A5066491567 @default.
• W2023321844 hasAuthorship W2023321844A5072000496 @default.
• W2023321844 hasAuthorship W2023321844A5074607712 @default.
• W2023321844 hasAuthorship W2023321844A5077029679 @default.
• W2023321844 hasAuthorship W2023321844A5079614063 @default.
• W2023321844 hasAuthorship W2023321844A5086062381 @default.
• W2023321844 hasBestOaLocation W20233218441 @default.
• W2023321844 hasConcept C124490489 @default.
• W2023321844 hasConcept C126322002 @default.
• W2023321844 hasConcept C126894567 @default.
• W2023321844 hasConcept C134018914 @default.
• W2023321844 hasConcept C142724271 @default.
• W2023321844 hasConcept C168563851 @default.
• W2023321844 hasConcept C204787440 @default.
• W2023321844 hasConcept C27081682 @default.
• W2023321844 hasConcept C2775945674 @default.
• W2023321844 hasConcept C2776079296 @default.
• W2023321844 hasConcept C2776541429 @default.
• W2023321844 hasConcept C2776886416 @default.
• W2023321844 hasConcept C2778838027 @default.
• W2023321844 hasConcept C2779126354 @default.
• W2023321844 hasConcept C2781208988 @default.
• W2023321844 hasConcept C2911091166 @default.
• W2023321844 hasConcept C519063684 @default.
• W2023321844 hasConcept C71924100 @default.
• W2023321844 hasConcept C90924648 @default.
• W2023321844 hasConceptScore W2023321844C124490489 @default.
• W2023321844 hasConceptScore W2023321844C126322002 @default.
• W2023321844 hasConceptScore W2023321844C126894567 @default.
• W2023321844 hasConceptScore W2023321844C134018914 @default.
• W2023321844 hasConceptScore W2023321844C142724271 @default.
• W2023321844 hasConceptScore W2023321844C168563851 @default.
• W2023321844 hasConceptScore W2023321844C204787440 @default.

• next